FGFR1 and sarcoma: TOP2A (DNA topoisomerase II alpha) and FGFR1 (fibroblast growth factor receptor 1) were the most frequently upregulated targets across all analyzed sarcoma samples (n=14/20 and n=9/20 biopsies, respectively).